Greenwich LifeSciences, Inc. GLSI NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

52/100

3/6 Pass

SharesGrow Intrinsic Value

合計 50 件の最近のインサイダー取引記録が記録されています Greenwich LifeSciences, Inc. (GLSI), 内訳は 50 件の買い および 0 件の売り. インサイダー買い総額は $24.19M インサイダー売り総額は RSU アワード.

最近活動のある主要インサイダーには Patel Snehal, Mcwilliams David, Thompson Jaye. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.

インサイダー取引記録 — GLSI

日付	氏名	役職	取引種別	株数	平均価格	価値	保有株数
2026-01-13	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	1,800	$29.83	$53.69K	5,604,102
2026-01-12	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	2,900	$27.54	$79.87K	5,602,302
2025-12-31	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	4,300	$21.36	$91.85K	5,599,402
2025-12-30	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	2,900	$21.73	$63.02K	5,595,102
2025-12-18	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	4,100	$12.62	$51.74K	5,592,202
2025-11-25	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	4,600	$8.37	$38.5K	5,588,102
2025-11-13	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	RSU 付与（制限付株式）	100,000	$8.20	$820K	2,347,462
2025-11-07	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	10,600	$8.43	$89.36K	5,583,502
2025-10-31	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	2,300	$9.26	$21.3K	5,572,902
2025-04-25	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	3,600	$9.88	$35.57K	5,570,602
2025-04-17	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	5,400	$8.98	$48.49K	5,567,002
2025-04-07	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	3,600	$9.10	$32.76K	5,561,602
2025-04-04	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	5,500	$8.73	$48.02K	5,558,002
2025-01-10	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	2,500	$12.51	$31.28K	5,552,502
2025-01-07	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	1,800	$13.75	$24.75K	5,550,002
2025-01-06	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	1,100	$13.31	$14.64K	5,548,202
2025-01-03	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	3,400	$12.95	$44.03K	5,547,102
2025-01-02	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	2,000	$11.97	$23.94K	5,543,702
2024-12-31	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	2,400	$11.36	$27.26K	5,541,702
2024-12-30	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	3,200	$11.12	$35.58K	5,539,302
2024-12-24	Mcwilliams David	Director	RSU 付与（制限付株式）	61,984	$12.16	$753.73K	123,968
2024-12-24	Thompson Jaye	VP Clinical Reg Affairs	RSU 付与（制限付株式）	149,818	$12.16	$1.82M	299,636
2024-12-24	Daugherty Frank Joseph	Chief Medical Officer	RSU 付与（制限付株式）	104,890	$12.16	$1.28M	209,780
2024-12-24	Rothe Eric	Director	RSU 付与（制限付株式）	41,349	$12.16	$502.8K	82,698
2024-12-24	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	RSU 付与（制限付株式）	1,148,723	$12.16	$13.97M	2,222,454
2024-12-24	Hallock Kenneth	Director	RSU 付与（制限付株式）	41,349	$12.16	$502.8K	82,698
2024-11-21	Thompson Jaye	VP Clinical Reg Affairs	情報に基づく買い	1,000	$12.91	$12.91K	264,148
2024-09-26	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	1,500	$14.63	$21.95K	5,536,102
2024-08-12	Thompson Jaye	VP Clinical Reg Affairs	情報に基づく買い	800	$13.85	$11.08K	263,148
2024-08-06	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	2,000	$13.81	$27.62K	5,534,602
2024-08-05	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	5,500	$13.18	$72.49K	5,532,602
2024-08-02	Thompson Jaye	VP Clinical Reg Affairs	情報に基づく買い	1,000	$15.15	$15.15K	262,348
2024-07-23	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	1,500	$15.89	$23.84K	5,527,102
2024-07-18	Thompson Jaye	VP Clinical Reg Affairs	情報に基づく買い	1,000	$16.00	$16K	261,348
2024-06-13	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	174,825	$14.30	$2.5M	5,525,602
2024-04-01	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	3,000	$19.08	$57.24K	5,350,777
2024-03-22	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	2,500	$19.98	$49.95K	5,347,777
2024-03-20	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	1,500	$17.68	$26.52K	5,345,277
2024-03-05	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	30,500	$12.49	$380.95K	5,343,777
2024-03-04	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	4,100	$13.03	$53.42K	5,340,277
2024-02-16	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	10,800	$11.16	$120.53K	5,336,177
2024-02-15	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	12,700	$11.07	$140.59K	5,325,377
2023-11-10	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	5,000	$10.17	$50.84K	5,312,677
2023-11-03	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	3,500	$9.11	$31.89K	5,307,677
2023-10-27	Thompson Jaye	VP Clinical Reg Affairs	情報に基づく買い	500	$8.57	$4.29K	260,348
2023-10-26	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	2,500	$7.97	$19.93K	5,304,177
2023-10-25	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	2,500	$7.91	$19.78K	5,301,677
2023-10-10	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	1,000	$9.07	$9.07K	5,299,177
2023-10-04	Patel Snehal	10 Percent Owner, Officer: CEO and CFO	情報に基づく買い	2,000	$8.63	$17.26K	5,298,177
2023-09-26	Thompson Jaye	VP Clinical Reg Affairs	情報に基づく買い	600	$8.71	$5.23K	259,848